vs
Side-by-side financial comparison of Allegion (ALLE) and Solventum (SOLV). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.0B, roughly 1.9× Allegion). Allegion runs the higher net margin — 13.4% vs 3.2%, a 10.2% gap on every dollar of revenue. On growth, Allegion posted the faster year-over-year revenue change (9.7% vs -3.7%). Over the past eight quarters, Allegion's revenue compounded faster (3.5% CAGR vs -0.4%).
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
ALLE vs SOLV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $2.0B |
| Net Profit | $138.1M | $63.0M |
| Gross Margin | 44.0% | 51.4% |
| Operating Margin | 18.9% | 6.3% |
| Net Margin | 13.4% | 3.2% |
| Revenue YoY | 9.7% | -3.7% |
| Net Profit YoY | -6.8% | 103.2% |
| EPS (diluted) | — | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $2.0B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.0B | $2.2B | ||
| Q1 25 | $941.9M | $2.1B | ||
| Q4 24 | $945.6M | $2.1B | ||
| Q3 24 | $967.1M | $2.1B | ||
| Q2 24 | $965.6M | $2.1B |
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $63.0M | ||
| Q3 25 | $188.4M | $1.3B | ||
| Q2 25 | $159.7M | $90.0M | ||
| Q1 25 | $148.2M | $137.0M | ||
| Q4 24 | $144.1M | $31.0M | ||
| Q3 24 | $174.2M | $122.0M | ||
| Q2 24 | $155.4M | $89.0M |
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 51.4% | ||
| Q3 25 | 45.8% | 54.2% | ||
| Q2 25 | 45.6% | 54.4% | ||
| Q1 25 | 44.9% | 53.8% | ||
| Q4 24 | 44.1% | 53.9% | ||
| Q3 24 | 44.7% | 56.0% | ||
| Q2 24 | 44.4% | 54.6% |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 6.3% | ||
| Q3 25 | 21.8% | 80.6% | ||
| Q2 25 | 21.5% | 9.9% | ||
| Q1 25 | 20.9% | 7.3% | ||
| Q4 24 | 19.5% | 6.6% | ||
| Q3 24 | 22.2% | 13.2% | ||
| Q2 24 | 21.6% | 11.7% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 3.2% | ||
| Q3 25 | 17.6% | 60.4% | ||
| Q2 25 | 15.6% | 4.2% | ||
| Q1 25 | 15.7% | 6.6% | ||
| Q4 24 | 15.2% | 1.5% | ||
| Q3 24 | 18.0% | 5.9% | ||
| Q2 24 | 16.1% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $0.37 | ||
| Q3 25 | $2.18 | $7.22 | ||
| Q2 25 | $1.85 | $0.51 | ||
| Q1 25 | $1.71 | $0.78 | ||
| Q4 24 | $1.65 | $0.18 | ||
| Q3 24 | $1.99 | $0.70 | ||
| Q2 24 | $1.77 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $308.9M | $878.0M |
| Total DebtLower is stronger | $2.0B | $5.0B |
| Stockholders' EquityBook value | $2.1B | $5.0B |
| Total Assets | $5.3B | $14.3B |
| Debt / EquityLower = less leverage | 0.97× | 1.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $878.0M | ||
| Q3 25 | $302.7M | $1.6B | ||
| Q2 25 | $656.8M | $492.0M | ||
| Q1 25 | $494.5M | $534.0M | ||
| Q4 24 | $503.8M | $762.0M | ||
| Q3 24 | $878.9M | $772.0M | ||
| Q2 24 | $747.5M | $897.0M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $5.0B | ||
| Q3 25 | $2.1B | $5.1B | ||
| Q2 25 | $2.1B | $7.8B | ||
| Q1 25 | $2.0B | $7.9B | ||
| Q4 24 | $2.0B | $8.0B | ||
| Q3 24 | $2.4B | $8.1B | ||
| Q2 24 | $2.4B | $8.3B |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $5.0B | ||
| Q3 25 | $1.9B | $5.0B | ||
| Q2 25 | $1.8B | $3.6B | ||
| Q1 25 | $1.6B | $3.3B | ||
| Q4 24 | $1.5B | $3.0B | ||
| Q3 24 | $1.6B | $3.2B | ||
| Q2 24 | $1.4B | $2.9B |
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $14.3B | ||
| Q3 25 | $5.2B | $14.0B | ||
| Q2 25 | $4.9B | $15.1B | ||
| Q1 25 | $4.6B | $14.5B | ||
| Q4 24 | $4.5B | $14.5B | ||
| Q3 24 | $5.0B | $14.7B | ||
| Q2 24 | $4.8B | $14.6B |
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 1.00× | ||
| Q3 25 | 1.07× | 1.03× | ||
| Q2 25 | 1.16× | 2.14× | ||
| Q1 25 | 1.24× | 2.43× | ||
| Q4 24 | 1.33× | 2.71× | ||
| Q3 24 | 1.53× | 2.54× | ||
| Q2 24 | 1.69× | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $101.3M | $95.0M |
| Free Cash FlowOCF − Capex | — | $32.0M |
| FCF MarginFCF / Revenue | — | 1.6% |
| Capex IntensityCapex / Revenue | 2.0% | 3.2% |
| Cash ConversionOCF / Net Profit | 0.73× | 1.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-10.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $95.0M | ||
| Q3 25 | $229.5M | $76.0M | ||
| Q2 25 | $209.7M | $169.0M | ||
| Q1 25 | $104.5M | $29.0M | ||
| Q4 24 | $219.0M | $219.0M | ||
| Q3 24 | $231.9M | $169.0M | ||
| Q2 24 | $173.0M | $355.0M |
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $32.0M | ||
| Q3 25 | $209.8M | $-21.0M | ||
| Q2 25 | $192.0M | $59.0M | ||
| Q1 25 | $83.4M | $-80.0M | ||
| Q4 24 | $194.9M | $92.0M | ||
| Q3 24 | $212.0M | $76.0M | ||
| Q2 24 | $152.1M | $297.0M |
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 1.6% | ||
| Q3 25 | 19.6% | -1.0% | ||
| Q2 25 | 18.8% | 2.7% | ||
| Q1 25 | 8.9% | -3.9% | ||
| Q4 24 | 20.6% | 4.4% | ||
| Q3 24 | 21.9% | 3.7% | ||
| Q2 24 | 15.8% | 14.3% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 3.2% | ||
| Q3 25 | 1.8% | 4.6% | ||
| Q2 25 | 1.7% | 5.1% | ||
| Q1 25 | 2.2% | 5.3% | ||
| Q4 24 | 2.5% | 6.1% | ||
| Q3 24 | 2.1% | 4.5% | ||
| Q2 24 | 2.2% | 2.8% |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 1.51× | ||
| Q3 25 | 1.22× | 0.06× | ||
| Q2 25 | 1.31× | 1.88× | ||
| Q1 25 | 0.71× | 0.21× | ||
| Q4 24 | 1.52× | 7.06× | ||
| Q3 24 | 1.33× | 1.39× | ||
| Q2 24 | 1.11× | 3.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
